Skip to content

Evaluation of Nutritional Status in Thalassemia Major Patients in Assiut Children Hospital

Evaluation of Nutritional Status in Patients With Thalassemia Major in Assiut University Children Hospital

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03161899
Enrollment
246
Registered
2017-05-22
Start date
2018-12-15
Completion date
2020-07-20
Last updated
2020-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thalassemia Major

Keywords

thalassemia - nutrition -growth

Brief summary

Thalassemia is a blood disorder passed down through families in which the body makes an abnormal form of hemoglobin. There are 2 main types of thalassemia; Alpha & Beta thalassemia. Alpha thalassemia: occurs when a gene or genes related to the alpha globin protein are missing or mutated. Beta-thalassemia syndromes are a group of hereditary blood disorders characterized by reduced or absent beta globin chain synthesis. Beta-thalassemias can be classified into: Silent carrier: completely asymptomatic with normal hematological parameters. Beta-thalassaemia minor (beta-thalassaemia trait): usually asymptomatic; diagnosis is made during a work-up for mild anemia. Beta-thalassaemia intermedia: usually a similar presentation to beta-thalassaemia major; symptoms are usually less pronounced and the course is usually more insidious. Beta-thalassaemia major : In which there is complete absence of hemoglobin A

Detailed description

In Egypt beta thalassemia-major is the most common type with carrier rate of 5.3 to ≥9%and 1000 new cases born with beta-thalassemia major per 1.5 million live births per year. Children born with thalassemia major are normal at birth, but develop severe hemolytic anemia during the first year of life. Symptoms are those of anemia (lethargy, poor feeding, pallor…etc.) failure to thrive and organomegaly. Later on they develop signs of extra medullary hematopoiesis . Optimal nutritional status is important for growth, immune function, bone health and pubertal development . Various reports suggest the incidence of poor growth ranges from 25% to 75% depending on thalassemia syndrome and severity of disease. This marked growth deficits raise a red flag for any pediatrician to evaluate nutritional status of thalassemic patients and detect possible nutritional deficiencies and associated factors. Etiology of delayed growth and malnutrition reported in thalassemic patient is multifactorial including : 1. Nutritional deprivation with or without feeding difficulties arising from fatigue and breathlessness 2. Increased energy expenditure secondary to hyper metabolism with or without heart failure 3. Gastrointestinal hypoxia which consequently produces anorexia and malabsorption 4. Reduction of biosynthetic activity of liver. 5. Disturbance of the endocrine function 6. Impaired synthetic hepatic function secondary to hemosiderosis and hepatitis. The main aim of this study is to assess the nutritional status of thalassemic patient attending Assiut university Children hospital and to determine the factors involved.

Interventions

None listed

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
6 Years to 14 Years
Healthy volunteers
No

Inclusion criteria

* patients diagnosed to have thalassemia

Exclusion criteria

* patient with any underlaying systemic diseases other than B thalassemia major.

Design outcomes

Primary

MeasureTime frameDescription
percentage of malnutrition12 monthprevalence of malnutrition among thalassemic children attending assiut university children hospital

Secondary

MeasureTime frameDescription
aetiology poor growth12 monthdetermination of the most common causes responsible for poor growth seen in thalassemic patients
decrease morbidity18 monthdecrease morbidity by providing possible strategies for early prevention of the problem of poor growth occurring in patients with thalassemia major

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026